Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03964337
Title Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer (SPARC)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

prostate adenocarcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.